Menu Search
Equities

Rite Aid Corp

RTA1:BER

Rite Aid Corp

Actions
  • Price (EUR)0.00
  • Today's Change0.00 / --
  • Shares traded0.00
  • 1 Year change-100.00%
  • Beta--
Data delayed at least 15 minutes, as of Jan 26 2024 19:31 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rite Aid Corporation is a full-service pharmacy engaged in improving health outcomes. The Company meets customer needs with a range of solutions that offer convenience, including retail and delivery pharmacy, as well as services offered through its wholly owned subsidiaries Health Dialog Services Corporation (Health Dialog) and Bartell Drug Company (Bartell Drugs). Health Dialog provides healthcare coaching and disease management services via live online and phone health services. Regional chain Bartell Drugs supports the health and wellness needs in the Seattle area. Its Retail Pharmacy segment’s primary business is the sale of prescription drugs and related consultation to its customers. Additionally, the Retail Pharmacy segment sells a full selection of health and beauty aids and personal care products, seasonal merchandise, and a large private brand product line. The Company operates more than 1,700 retail pharmacy locations across 16 states.

  • Revenue in USD (TTM)23.48bn
  • Net income in USD-1.64bn
  • Incorporated1968
  • Employees47.00k
  • Location
    Rite Aid Corp1200 INTREPID AVENUE, 2ND FLOORPHILADELPHIA 19112United StatesUSA
  • Phone+1 (717) 761-2633
  • Fax+1 (302) 655-5049
  • Websitehttps://www.riteaid.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.